| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/23/1996 | CA2204870A1 Ribozyme analogs |
| 05/23/1996 | CA2204767A1 Pyrrolidinyl di-carboxylic acid derivatives as metabotropic glutamate receptor agonists |
| 05/23/1996 | CA2204669A1 Novel nucleic acid molecules comprising the prostate specific antigen (psa) promoter and uses thereof |
| 05/23/1996 | CA2204630A1 Regulation of neural stem cell proliferation |
| 05/23/1996 | CA2204598A1 Eleutherobin and analogs thereof |
| 05/23/1996 | CA2204145A1 Acne treating-wound healing compositions containing a pyruvate, an antioxidant and a mixture of fatty acids |
| 05/23/1996 | CA2204030A1 Oxazolyl- and thiazolylimidazo-benzo- and thienodiazepines and their use as medicaments |
| 05/23/1996 | CA2203681A1 Cyclic amidine analogs as inhibitors of nitric oxide synthase |
| 05/23/1996 | CA2203654A1 Human stanniocalcin-alpha |
| 05/23/1996 | CA2203517A1 Pharmaceutical pyrazole compositions useful as inhibitors of protein kinases |
| 05/23/1996 | CA2203375A1 Low molecular weight peptidomimetic growth hormone secretagogues |
| 05/23/1996 | CA2202760A1 Multicatalytic protease inhibitors |
| 05/23/1996 | CA2202135A1 Pyridazinoquinoline compounds |
| 05/23/1996 | CA2202051A1 Nonpeptide endothelin antagonists |
| 05/23/1996 | CA2201736A1 Bicyclic oxazine and thiazine oxazolidinone antibacterials |
| 05/23/1996 | CA2199964A1 6-aryl pyrido[2,3-d]pyrimidines and naphthyridines for inhibiting protein tyrosine kinase mediated cellular proliferation |
| 05/22/1996 | EP0712936A1 Low-molecular dna from sturgeon mult, a method of obtaining the dna and a pharmaceutical preparation based on it |
| 05/22/1996 | EP0712864A2 Non-absorbable synthetic sulfated polysaccharides |
| 05/22/1996 | EP0712855A1 Solar filters, cosmetic photoprotective compositions and their use |
| 05/22/1996 | EP0712837A2 Ring-substituted 2-amino-1,2,3,4-tetra-hydronaphthalenes and 3-aminochromanes |
| 05/22/1996 | EP0712631A2 Cyclosporin containing multiple emulsions |
| 05/22/1996 | EP0712629A1 Acyl deoxyribonucleoside derivatives and uses thereof |
| 05/22/1996 | EP0712628A2 Methods of inhibiting bone loss |
| 05/22/1996 | EP0712627A2 Methods for lowering serum cholesterol |
| 05/22/1996 | EP0712626A2 Use of R,S-(+/-)-alpha-Lipoic acid, S-(-)-alpha-Lipoic acid in reduced or oxidized form or their metabolites as well as their salts, esters, amides for the manufacture of rheological agents |
| 05/22/1996 | EP0712583A2 Total parenteral nutrition solution containing watersoluble vitamin B |
| 05/22/1996 | EP0712493A1 A method for preparing and selecting pharmaceutically useful non-peptide compounds from a structurally diverse universal library |
| 05/22/1996 | EP0712412A1 15,15-dialkyl-substituted derivatives of estradiol |
| 05/22/1996 | EP0712406A1 Condensed indole derivatives as 5-ht 4-receptor antagonists |
| 05/22/1996 | EP0712405A1 Derivatives of monic acids a and c having antibacterial, antimycoplasmatical, antifungal and herbicidal activity |
| 05/22/1996 | EP0712402A1 Hydroisoquinoline derivatives |
| 05/22/1996 | EP0712401A1 Novel dialkoxy-pyridinyl-benzimidazole derivatives |
| 05/22/1996 | EP0712400A1 Novel substituted benzimidazoles |
| 05/22/1996 | EP0712397A1 Amide derivatives as 5ht1d receptor antagonists |
| 05/22/1996 | EP0712390A1 Succinamide derivatives, processes for their preparation and their use as gelatinase and collagenase inhibitors |
| 05/22/1996 | EP0712389A1 Therapeutic compound - fatty acid conjugates |
| 05/22/1996 | EP0712388A1 Use of phenols and phenol derivates as medicaments with fibrinogen-reducing effect |
| 05/22/1996 | EP0712387A1 2-aminoindans as selective dopamine d3 ligands |
| 05/22/1996 | EP0712313A1 Pro-cytotoxic drug conjugates for anticancer therapy |
| 05/22/1996 | EP0712311A1 Antiglucocorticoid steroids for the treatment of anxiety disorders |
| 05/22/1996 | EP0712310A1 Use of tumor necrosis factor inhibitors together with antiviral agents and therapeutic compositions thereof against hiv infection |
| 05/22/1996 | EP0712303A1 Skin patches and methods for providing testosterone |
| 05/22/1996 | EP0712277A1 Jak kinases and regulation of cytokine signal transduction |
| 05/22/1996 | EP0677056B1 Oligonucleotide alkylphosphonates and alkylphosphonothioates |
| 05/22/1996 | EP0673376B1 Bicyclic pyrimidine compounds, method for preparing same and pharmaceutical compositions containing said compounds |
| 05/22/1996 | EP0637299B1 20-methyl-substituted vitamin d derivates |
| 05/22/1996 | EP0589034A4 Method for making 3-g(a)-hydroxy,3-g(b)-substituted-pregnanes |
| 05/22/1996 | EP0539470B1 Neuromuscular blocking agents |
| 05/22/1996 | CN1123038A Antisense oligonucleotides which combat aberrant splicing and methods of using the same |
| 05/22/1996 | CN1123030A Inclusion complexes of taxol or taxotere or taxus extract formed with cyclodextrins, its preparation and use |
| 05/22/1996 | CN1123027A Novel aconitine-like compound and antipyretic analgesic anti-inflammatory agent |
| 05/22/1996 | CN1123005A Compositions, for inhibition, control and regression of angiogenesis, containing hyaluronic acid and nsaid |
| 05/22/1996 | CN1122804A 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative |
| 05/22/1996 | CN1122803A Benzoxazolyl- and benzothiazolyloxazolidinones |
| 05/22/1996 | CN1122710A Compound prepn. made from herb medicine and western medicine for treating poultry dysentery with white mucous stool |
| 05/22/1996 | CN1122693A Medical use of RNA from poultry embryo |
| 05/22/1996 | CN1122692A Oral anthelmintic tablet |
| 05/22/1996 | CN1031827C Process for preparation of substituted benzimidazoles |
| 05/22/1996 | CN1031826C Pyrazolopyrimidine and pyrimidinyl bisphosphonic esters as anti-inflammatories |
| 05/22/1996 | CN1031825C Process for preparing heteroaroyl derivatives of monocyclic beta-lactam antibiotics |
| 05/22/1996 | CN1031824C Process for preparing new thiazolidinone and oxazolidinone derivatives |
| 05/21/1996 | US5519163 Inhibitors of phosphoinositide-specific phospholipase C |
| 05/21/1996 | US5519155 Platinum complexes |
| 05/21/1996 | US5519138 Angiotensin antagonist |
| 05/21/1996 | US5519134 Pyrrolidine-containing monomers and oligomers |
| 05/21/1996 | US5519131 Synthesis of pyridooxazinyl-indoles |
| 05/21/1996 | US5519126 Combatting diseases by biochemicl intervention at the rna and dna level |
| 05/21/1996 | US5519123 Chelating agents, their preparation from the antibiotics salmycin A,B,C, or D, and their use |
| 05/21/1996 | US5519062 1-alkyl, 1-alkenyl-, and 1-alkynylaryl-2-amino-1,3-propanediols and related compounds |
| 05/21/1996 | US5519061 Monoamine oxidase inhibitors, parkinson's disease |
| 05/21/1996 | US5519060 Enzyme inhibitors |
| 05/21/1996 | US5519059 Of isopropyl alcohol, isopropyl myristate, polyoxyethylene glycol and tolnaftate |
| 05/21/1996 | US5519058 Method for treatment with dimercaptosuccinic acid (DMSA) of hypertension, diabetic neuphropathy and atherosclerosis |
| 05/21/1996 | US5519057 Ibuprofen-containing medicament |
| 05/21/1996 | US5519056 Fungicides against candida or aspergillus |
| 05/21/1996 | US5519055 Enzyme inhibitors |
| 05/21/1996 | US5519054 Pharmaceutical compositions containing N-acetyl-cysteine derivatives useful for the treatment of cataract |
| 05/21/1996 | US5519053 5-Iodo-6-amino-1,2-Benzopyrones and their metabolites useful as cytostatic agents |
| 05/21/1996 | US5519049 Macrolides for the treatment of reversible obstructive airways diseases |
| 05/21/1996 | US5519047 Decreasing elevated levels of interleukins and interferons |
| 05/21/1996 | US5519046 Ketorolac-containing fomentation |
| 05/21/1996 | US5519044 Serotonin m receptor antagonists, treatment of drug addiction |
| 05/21/1996 | US5519042 Method of treating hyperproliferative vascular disease |
| 05/21/1996 | US5519041 Anticarcinogenic agents from polyamide derivatives |
| 05/21/1996 | US5519039 Pantothenic acid, nicotinic acid and biotin for skins |
| 05/21/1996 | US5519036 Cyclic derivatives pharmaceutical compositions containing these compounds and processes for preparing them |
| 05/21/1996 | US5519035 Treatment of stroke or in anticipation of the occurrence of brain ischemia |
| 05/21/1996 | US5519034 Analgesics |
| 05/21/1996 | US5519033 Azabicyclo derivatives for treatment of urinary incontinence |
| 05/21/1996 | US5519032 Antidepressants, anxiolytics, antiemetics, antipsychotic |
| 05/21/1996 | US5519031 Carbamates of rapamycin |
| 05/21/1996 | US5519030 Method for prophylaxis and treatment of myopia |
| 05/21/1996 | US5519028 Antiviral preparations |
| 05/21/1996 | US5519027 D-homo-(16-ene)-11β-aryl-4-estrenes, process for their production as well as their use as pharmaceutical agents |
| 05/21/1996 | US5519025 Anxiolytic and antidepressant agents |
| 05/21/1996 | US5519023 New aminoalkylchromones, processes for the preparation thereof |
| 05/21/1996 | US5519022 α, α dialkylbenzyl derivatives |
| 05/21/1996 | US5519021 Benzoxazinones as inhibitors of HIV reverse transcriptase |
| 05/21/1996 | US5519020 Polymer adducts which release nitric oxide |
| 05/21/1996 | US5519018 Substituted phenols and their use for the treatment of disorders caused by cell proliferation |